Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27.
Clin Exp Dermatol
; 32(1): 57-9, 2007 Jan.
Article
en En
| MEDLINE
| ID: mdl-17305906
ABSTRACT
We describe a patient with Sézary syndrome (SS) who was successfully treated with topical steroid and narrowband UVB. Sézary cells in peripheral blood correlated with severity of skin lesions. In addition, serum levels of CCL17 and CCL27 decreased as disease activity improved. These chemokines may be important for the pathogenesis of SS.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Terapia Ultravioleta
/
Síndrome de Sézary
/
Quimiocinas CC
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Clin Exp Dermatol
Año:
2007
Tipo del documento:
Article
País de afiliación:
Japón